CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT.
Aurinia Pharmaceuticals Inc.
Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
044
*IDENTIFICATION
Medical information services, namely, providing health and medical information in the field of diagnostic and treatment of autoimmune
disorders, kidney disorders, opthamalogical disorders and lupus nephritis; conducting medical studies in the field of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus
nephritis; medical evaluation services, namely conducting patients studies and functional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and
assessment program effectiveness
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME
Matthew R. Wilmot
ATTORNEY DOCKET NUMBER
66570-15
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Stoel Rives LLP
STREET
760 SW Ninth Avenue, Suite 3000
CITY
Portland
STATE
Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
97205
PHONE
503-294-9851
FAX
503-220-2480
EMAIL ADDRESS
TM-PDX@STOEL.COM
OTHER APPOINTED ATTORNEY
Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Catherine P. Lake, Joshua G. Gigger
CORRESPONDENCE INFORMATION
NAME
Matthew R. Wilmot
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
TM-PDX@STOEL.COM
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEES DUE
550
*TOTAL FEES PAID
550
SIGNATURE INFORMATION
SIGNATURE
/Erik Eglite/
SIGNATORY'S NAME
Dr. Erik Eglite
SIGNATORY'S POSITION
Senior Vice President, General Counsel
SIGNATORY'S PHONE NUMBER
503-294-9851
DATE SIGNED
05/07/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88907266
Filing Date:05/08/020
To the Commissioner for Trademarks:
MARK: CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT. (Standard Characters, see mark)
The literal element of the mark consists of CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT.. The mark consists of standard characters, without claim to any
particular font style, size, or color.
The applicant, Aurinia Pharmaceuticals Inc., a company organized under the laws of Canada, having an address of
1203-4464 Markham Street
Victoria, BC V8Z7X8
Canada
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 042: Research and development of medicinals and pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Canada application number 2024836, filed 04/27/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 044: Medical information services, namely, providing health and medical information in the field of diagnostic and treatment of autoimmune disorders, kidney disorders,
opthamalogical disorders and lupus nephritis; conducting medical studies in the field of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis; medical evaluation
services, namely conducting patients studies and functional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and assessment program
effectiveness
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Canada application number 2024836, filed 04/27/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
The owner's/holder's proposed attorney information: Matthew R. Wilmot. Other appointed attorneys are Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Catherine P. Lake,
Joshua G. Gigger. Matthew R. Wilmot of Stoel Rives LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
760 SW Ninth Avenue, Suite 3000
Portland, Oregon 97205
United States
503-294-9851(phone)
503-220-2480(fax)
TM-PDX@STOEL.COM
The docket/reference number is 66570-15.
Matthew R. Wilmot submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Matthew R. Wilmot
PRIMARY EMAIL FOR CORRESPONDENCE: TM-PDX@STOEL.COM SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Erik Eglite/ Date: 05/07/2020
Signatory's Name: Dr. Erik Eglite
Signatory's Position: Senior Vice President, General Counsel
Payment Sale Number: 88907266
Payment Accounting Date: 05/08/2020
Serial Number: 88907266
Internet Transmission Date: Fri May 08 15:26:44 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202005081526441
94525-88907266-7104fd660c45f6d4e198eda74
39b681aefafaca7f4c791228f36635a94996c8a8
94-CC-26421197-20200506203436455071